Single-energy material decomposition using X-ray path length estimation.

J Comput Assist Tomogr

Department of Optics and Quantum Electronics, University of Szeged, Szeged, Hungary.

Published: February 2013

Objective: Clinical computed tomographies (CTs) can typically use only a single energy at a time. The main purpose of the present paper was to study whether the calculated x-ray path lengths can help replace one of the 2 dual-energy measurements by 2-material decomposition.

Method: The proposed single-energy material decomposition method (SEMD) is based on the evaluation of a single CT scan. The SEMD combines postreconstruction and prereconstruction algorithms for the determination of x-ray path length and material decomposition, respectively.

Results: The simulation results of the proposed and dual-energy methods were compared using pregenerated look-up tables. The results show that SEMD is more sensitive to CT signal errors at higher tube voltages. The dual-energy method is generally less sensitive to CT signal bias but more sensitive to the noise.

Conclusions: In the case of inferior signal errors, the proposed method gives the same results as the dual-energy variant. Although the x-ray path length estimation method with SEMD is more complex, the dose is considerably lower.

Download full-text PDF

Source
http://dx.doi.org/10.1097/RCT.0b013e318267ab96DOI Listing

Publication Analysis

Top Keywords

x-ray path
16
material decomposition
12
path length
12
single-energy material
8
length estimation
8
method semd
8
sensitive signal
8
signal errors
8
x-ray
4
decomposition x-ray
4

Similar Publications

Artificial intelligence and stroke imaging.

Curr Opin Neurol

February 2025

High Dimensional Neurology Group, UCL Queen Square Institute of Neurology, University College London, Russell Square House, Bloomsbury, London, UK.

Article Synopsis
  • The review highlights the complexity of stroke, driven by disruptions in blood supply and complicated by the neural and vascular systems' interactions.
  • Advances in machine vision and deep learning are improving predictive tools for stroke, but their clinical impact is limited by real-world data challenges.
  • Although AI's potential benefits for stroke care are clear, the best approaches for practical application are still being explored, with deep generative models seen as a promising avenue for innovation.
View Article and Find Full Text PDF
Article Synopsis
  • The study aims to improve visualization of arteries during endovascular procedures for peripheral artery disease by using an image registration technique that fuses X-ray and CT angiography images.
  • The method involved aligning digital images based on the positions of the bones and achieved successful registration in most cases, with accurate alignment of less than 1 mm in distance.
  • The results indicate that this technique is clinically viable for guiding interventions, as it allows for early detection of potential complications like guidewire perforations while maintaining a reasonable processing time.
View Article and Find Full Text PDF

Liquid biomarkers are essential in trauma cases and critical care and offer valuable insights into the extent of injury, prognostic predictions, and treatment guidance. They can help assess the severity of organ damage (OD), assist in treatment decisions and forecast patient outcomes. Notably, small extracellular vesicles, particularly those involved in splenic trauma, have been overlooked.

View Article and Find Full Text PDF

The circle of Willis (CoW) is a circular arrangement of arteries in the human brain, exhibiting significant anatomical variability. The CoW is extensively studied in relation to neurovascular pathologies, with certain anatomical variants previously linked to ischemic stroke and intracranial aneurysms. In an individual CoW, arteries might be absent (aplasia) or underdeveloped (hypoplasia, diameter < 1 mm).

View Article and Find Full Text PDF

Theranostic drugs represent an emerging path to deliver on the promise of precision medicine. However, bottlenecks remain in characterizing theranostic targets, identifying theranostic lead compounds, and tailoring theranostic drugs. To overcome these bottlenecks, we present the Theranostic Genome, the part of the human genome whose expression can be utilized to combine therapeutic and diagnostic applications.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!